In focus · trending topic

atlantic pharmaceuticals

36 stories · following the connections

Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative Colitis

By Nasdaq OMXMay 30, 2017, 12:28 PM UTC

Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative Colitis

By Nasdaq OMXMay 30, 2017, 12:27 PM UTC

Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative Colitis

By Nasdaq OMXMay 30, 2017, 12:27 PM UTC

Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative Colitis

By Nasdaq OMXMay 30, 2017, 12:27 PM UTC

Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative Colitis

By Nasdaq OMXMay 30, 2017, 12:27 PM UTC

Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative Colitis

By Nasdaq OMXMay 30, 2017, 12:27 PM UTC

Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative Colitis

By Nasdaq OMXMay 30, 2017, 12:27 PM UTC

Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative Colitis

By Nasdaq OMXMay 30, 2017, 12:27 PM UTC